Cleared Traditional

K032257 - MODEL IR 1200 INSULIN PUMP

K032257 is an FDA 510(k) clearance for MODEL IR 1200 INSULIN PUMP, manufactured by Animas Corp.. The device is a Class 2 General Hospital device with product code LZG cleared through the Traditional 510(k) pathway after a 86-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2003
Decision
86d
Days
Class 2
Risk

K032257 is an FDA 510(k) clearance for the MODEL IR 1200 INSULIN PUMP. Classified as Pump, Infusion, Insulin (product code LZG), Class II - Special Controls.

Submitted by Animas Corp. (Frazer, US). The FDA issued a Cleared decision on October 16, 2003 after a review of 86 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5725 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K032257

510(k) Number K032257 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2003
Decision Date October 16, 2003
Days to Decision 86 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 129d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZG Device Classification - Class 2, Special Controls

Product Code LZG Pump, Infusion, Insulin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LZG Pump, Infusion, Insulin

All 83
Devices cleared under the same product code (LZG) and FDA review panel - the closest regulatory comparables to K032257.
IXL DIABETES MANAGEMENT SYSTEM
K031373 · Insulet Corp. · Dec 2003
PARADIGMPAL, MODEL MMT-7330
K031541 · Minimed, Inc. · Nov 2003
DIABETES DATA MANAGEMENT SYSTEM (DDMS), MODEL 7333
K032164 · Medtronic Minimed · Oct 2003
MEDTRONIC MINIMED PARADIGM MODEL 512 INSULIN PUMP AND THE BD PARADIGM LINK GLUCOSE METER
K030531 · Minimed, Inc. · Jun 2003
EZMANAGER PLUS
K022394 · Animas Corp. · Jun 2003
DISETRONIC H-TRONPLUS INSULIN INFUSION PUMP
K023471 · Disetronic Medical Systems AG · Oct 2002